Shares of ImmuPharma plc (LON:IMM – Get Free Report) were up 18.3% during mid-day trading on Friday . The stock traded as high as GBX 4.50 ($0.06) and last traded at GBX 4.26 ($0.05). Approximately 26,333,650 shares traded hands during mid-day trading, an increase of 36% from the average daily volume of 19,375,852 shares. The stock had previously closed at GBX 3.60 ($0.04).
ImmuPharma Stock Performance
The firm has a market cap of £16.39 million, a P/E ratio of -393.60 and a beta of 1.53. The business’s 50-day simple moving average is GBX 1.75 and its 200 day simple moving average is GBX 1.73.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Recommended Stories
- Five stocks we like better than ImmuPharma
- Do ETFs Pay Dividends? What You Need to Know
- Bloom Energy: Powering the Future With Decentralized Energy
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What is a Special Dividend?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240417094222&h=45&w=95&zc=2){kind=logo}